We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Axon's Q1 Earnings Top Estimates on Solid Software & Services Sales
Read MoreHide Full Article
Axon Enterprise, Inc. (AXON - Free Report) reported first-quarter 2025 adjusted earnings of $1.41 per share, which surpassed the Zacks Consensus Estimate of $1.27. The bottom line surged 22.6% year over year despite a significant rise in the cost of sales.
Total revenues of $603.6 million surpassed the consensus estimate of $589 million and increased 31.3% year over year. The top line benefited from strong demand for TASER 10 and Axon Body 4. Growing demand for platform sensors also augmented the top-line results. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
AXON’s Q1 Business Segment Performance
Effective first-quarter 2025, AXON realigned its business segments. The company now reports results under two business segments, namely Connected Devices and Software & Services.
Connected Devices: The segment’s revenues jumped 26% year over year to $340.9 million, driven by growth in demand for TASER 10 devices and associated cartridges, and Axon Body 4 as well as growth in platform solutions. The adjusted gross margin decreased year over year to 52.8% from 54.1%.
Software & Services: The segment’s revenues rose 39% year over year to $262.7 million. The uptick was driven by an increase in the aggregate number of users and growing adoption of premium add-on features by existing customers. The adjusted gross margin increased to 77.7% from 76.1% in the year-ago period due to a higher software mix.
Axon Enterprise, Inc Price, Consensus and EPS Surprise
Axon’s cost of sales increased 18.2% year over year to $237.9 million. Selling, general and administrative expenses increased 48% year over year to $223.5 million.
Total operating expenses climbed 54.7% year over year to $374.5 million. The adjusted gross margin increased to 63.6% from 63.2% in the year-ago period.
AXON’s Balance Sheet & Cash Flow
At the end of first-quarter 2025, Axon had cash and cash equivalents of $1.09 billion compared with $454.8 million at December 2024-end. Long-term lease liabilities totaled $40 million compared with $41.4 million at 2024-end.
In the first three months of 2025, the company generated net cash of $25.8 million from operating activities against $15.9 million in cash spent in the previous year.
Adjusted free cash flow was $932 million in the first three months of 2025 compared with $32.1 million in the prior year.
AXON’s Outlook for 2025
For 2025, Axon expects revenues to be in the band of $2.60-$2.70 billion compared with $2.55-$2.65 billion anticipated earlier. The metric indicates approximately 27% year-over-year growth at the midpoint. Adjusted EBITDA is expected to be in the range of $650-$675 million, implying an adjusted EBITDA margin of about 25%.
The company expects capital expenditures to be between $160 million and $180 million. This includes investments in long-term research & development projects, continued capacity expansion, global facility build-outs and new product development. It anticipates stock-based compensation expenses to be in the range of $580-$630 million.
AXON’s Zacks Rank
The company currently carries a Zacks Rank #4 (Sell).
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share in the second quarter of fiscal 2025 (ended March 2025), beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Axon's Q1 Earnings Top Estimates on Solid Software & Services Sales
Axon Enterprise, Inc. (AXON - Free Report) reported first-quarter 2025 adjusted earnings of $1.41 per share, which surpassed the Zacks Consensus Estimate of $1.27. The bottom line surged 22.6% year over year despite a significant rise in the cost of sales.
Total revenues of $603.6 million surpassed the consensus estimate of $589 million and increased 31.3% year over year. The top line benefited from strong demand for TASER 10 and Axon Body 4. Growing demand for platform sensors also augmented the top-line results. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
AXON’s Q1 Business Segment Performance
Effective first-quarter 2025, AXON realigned its business segments. The company now reports results under two business segments, namely Connected Devices and Software & Services.
Connected Devices: The segment’s revenues jumped 26% year over year to $340.9 million, driven by growth in demand for TASER 10 devices and associated cartridges, and Axon Body 4 as well as growth in platform solutions. The adjusted gross margin decreased year over year to 52.8% from 54.1%.
Software & Services: The segment’s revenues rose 39% year over year to $262.7 million. The uptick was driven by an increase in the aggregate number of users and growing adoption of premium add-on features by existing customers. The adjusted gross margin increased to 77.7% from 76.1% in the year-ago period due to a higher software mix.
Axon Enterprise, Inc Price, Consensus and EPS Surprise
Axon Enterprise, Inc price-consensus-eps-surprise-chart | Axon Enterprise, Inc Quote
AXON’s Margin Profile
Axon’s cost of sales increased 18.2% year over year to $237.9 million. Selling, general and administrative expenses increased 48% year over year to $223.5 million.
Total operating expenses climbed 54.7% year over year to $374.5 million. The adjusted gross margin increased to 63.6% from 63.2% in the year-ago period.
AXON’s Balance Sheet & Cash Flow
At the end of first-quarter 2025, Axon had cash and cash equivalents of $1.09 billion compared with $454.8 million at December 2024-end. Long-term lease liabilities totaled $40 million compared with $41.4 million at 2024-end.
In the first three months of 2025, the company generated net cash of $25.8 million from operating activities against $15.9 million in cash spent in the previous year.
Adjusted free cash flow was $932 million in the first three months of 2025 compared with $32.1 million in the prior year.
AXON’s Outlook for 2025
For 2025, Axon expects revenues to be in the band of $2.60-$2.70 billion compared with $2.55-$2.65 billion anticipated earlier. The metric indicates approximately 27% year-over-year growth at the midpoint. Adjusted EBITDA is expected to be in the range of $650-$675 million, implying an adjusted EBITDA margin of about 25%.
The company expects capital expenditures to be between $160 million and $180 million. This includes investments in long-term research & development projects, continued capacity expansion, global facility build-outs and new product development. It anticipates stock-based compensation expenses to be in the range of $580-$630 million.
AXON’s Zacks Rank
The company currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Companies
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share in the second quarter of fiscal 2025 (ended March 2025), beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.